Recruiting
Registry of Asthma Characterization and Recruitment 3 (RACR3)
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
ClinicalTrials.gov IDNCT05272241
PhaseNot Applicable
Enrollment1500
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
AgeNo minimum reported
SexALL
Conditions studied
Asthma
About this study
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
Primary outcomes
- Number of participants with asthma and allergy characteristics (7 years)
Eligibility information
Inclusion Criteria:
1. Participant is either:
1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)
Exclusion Criteria:
1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.
Study locations
- Children's Hospital Colorado: Allergy Program, Aurora, Colorado 80045 United States
- Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site, Washington D.C., District of Columbia 20010 United States
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago, Illinois 60611 United States
- Boston Children's Hospital: Department of Immunology, Boston, Massachusetts 02215 United States
- Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute, New York, New York 10029 United States
- Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, New York, New York 10032 United States
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati, Ohio 45229 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.